Connor Quinn - Arvinas, LLC | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 5 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Co-opting the E3 Ligase KLHDC2 for Targeted Protein Degradation by Small Molecules

Christopher M. Hickey, Katherine M. Digianantonio,Kurt Zimmermann,Alicia Harbin,Connor Quinn, Avani Patel,Peter Gareiss, Amanda Chapman, Bernadette Tiberi, Jennifer Dobrodziej,John Corradi,Angela M. Cacace,David R. Langley,Miklós Békés

NATURE STRUCTURAL & MOLECULAR BIOLOGYno. 2 (2024)

Cited0Views0WOSNATUREBibtex

PROTACs Targeting BRM (SMARCA2) Afford Selective in Vivo Degradation over BRG1 (SMARCA4) and Are Active in BRG1 Mutant Xenograft Tumor Models

Michael Berlin,Jennifer Cantley,Mark Bookbinder,Elizabeth Bortolon,Fabio Broccatelli,Greg Cadelina,Emily W. Chan,Huifen Chen,Xin Chen,Yunxing Cheng,Tommy K. Cheung, Kim Davenport, Dean DiNicola,Debbie Gordon,Brian D. Hamman,Alicia Harbin,Roy Haskell,Mingtao He,Alison J. Hole,Thomas Januario,Philip S. Kerry,Stefan G. Koenig, Limei Li,Mark Merchant, Inmaculada Perez-Dorado,Jennifer Pizzano,Connor Quinn,Christopher M. Rose,Emma Rousseau,Leofal Soto,Leanna R. Staben, Hongming Sun,Qingping Tian, Jing Wang, Weifeng Wang, Crystal S. Ye,Xiaofen Ye, Penghong Zhang,Yuhui Zhou,Robert Yauch,Peter S. Dragovich

Journal of Medicinal Chemistryno. 2 (2024): 1262-1313

Cited0Views0WOSBibtex

Oral Estrogen Receptor PROTAC Vepdegestrant (ARV-471) is Highly Efficacious As Monotherapy and in Combination with CDK4/6 or PI3K/mTOR Pathway Inhibitors in Preclinical ER+ Breast Cancer Models

Sheryl M. Gough,John J. Flanagan,Jessica Teh,Monica Andreoli,Emma Rousseau, Melissa Pannone,Mark Bookbinder,Ryan Willard, Kim Davenport,Elizabeth Bortolon,Gregory Cadelina,Debbie Gordon,Jennifer Pizzano,Jennifer Macaluso,Leofal Soto,John Corradi, Katherine Digianantonio,Ieva Drulyte,Alicia Morgan,Connor Quinn,Miklos Bekes,Caterina Ferraro,Xin Chen,Gan Wang,Hanqing Dong, Jing Wang,David R. Langley,John Houston,Richard Gedrich,Ian C. Taylor

CLINICAL CANCER RESEARCHno. 16 (2024): 3549-3563

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn